Eisai Enters Into Agreement With National Cancer Center to Collaborate on Investigator-Initiated Clinical Research for Anticancer Agent Tazemetostat Based on “Patient-Proposed Healthcare Services” System

via Kuala Lumpur Week https://ift.tt/xTmhDoP